Representation of treatment options for HCC (IMAGE)
Caption
Patients who are not eligible for surgical resection may or may not be eligible for liver transplant, depending on the extent of their disease, as outlined by the Milan and other criteria above. Some patients who are eligible for liver transplant may experience long wait times, necessitating bridging therapies to prevent disease progression while awaiting LT. Guidelines support the use of bridging therapy for UNOS Stage T2 lesions if the wait time is expected to be six months or longer. The fig summarizes the main treatment strategies for HCC.
Credit
Ahmet Gurakar, Lynette M. Sequeira
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC